A Therapeutic for Radiation Induced Lung Injury
Award amount
$299,948Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Angion Biomedica Corp.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- FCRJS1FGND63
- Solicitation number
- PA12-044
- Topic code
- NIAID
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Targeted Therapeutics for Liver Disease
- ROCK selective inhibitor for Chronic Kidney Disease
- Steroid β hydroxylase inhibitor for Cushing s Syndrome
- Aldosterone Synthase Inhibitor for CKD
- A Novel Small Molecule Therapeutic for Alcoholic Chronic Pancreatitis
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
Research funding history
75 SBIR/STTR records share this UEI (1999–2019). Reported award amounts total $60,879,018. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation